12.890

-0.020 (-0.15%)
Range 12.725 - 13.630   (7.11%)
Open 12.890
Previous Close 12.910
Buy Price 12.760
Buy Volume 8
Sell Price 13.000
Sell Volume 8
Volume 63,601
Value -
Remark
Measurement Type Value
EPS (USD) -2.575
Trailing EPS (USD) -3.792
NAV (USD) 4.318
Cash In Hand (USD) 4.57
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 2.99
Price / Cash In Hand 2.825
Issued & Paid-up Shares 8,114,360
Treasury Shares -
Market Cap (M) 104.756
Par Value (USD) n.a.
Beta - 75 Days 0.768
R-Squared - 75 Days(%) 4.59
Beta - 500 Days 1.074
R-Squared - 500 Days(%) 0.03
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 28 Nov 2020 02:00.
Data powered by

Upcoming Events

* Stock event date based on US timezone.

Earnings

Release Date 23 Mar 2021
View All Events

About DARIOHEALTH CORP

Labstyle Innovations Corp is an Israel-based developer of the Dario diabetes management solution. It is engaged in developing and commercializing patent-pending technology that is seeking to bring clinical laboratory testing capabilities to consumers through the use of smartphones. The Company’s initial product is Dario, which is a device and software system for patient self-monitoring of blood glucose (SMBG). Dario is a patent pending system, which combines an all-in-one SMBG device consisting of a lancet to obtain a blood sample, a device-specific disposable test strip cartridge and a smartphone driven glucose reader adaptor to hold the strip and interface with the smartphone, coupled with a smartphone application and Internet-based data services. Dario will offer millions of diabetics, and in particular insulin dependent diabetics, a new option to the SMBG test kits.

Loading Chart...